Fat-free mass index and apixaban exposure in frail hospitalized older adults: An exploratory study

Tancrède de Jerphanion, Olivier Brière, Jennifer Gautier, Alexis Bourgeais, Myriam Mellou, Léa Bourreau, Cédric Annweiler, Mathieu Corvaisier · 2026

Read Fat-free mass index and apixaban exposure in frail hospitalized older adults: An exploratory study by Tancrède de Jerphanion, Olivier Brière, Jennifer Gautier, Alexis Bourgeais, Myriam Mellou, Léa Bourreau, Cédric Annweiler, Mathieu Corvaisier (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571488.txt.

Description

Tancrède de Jerphanion and co-authors report an exploratory study, published in 2026, on body composition and blood levels of a stroke prevention drug in frail older patients. Apixaban thins the blood, and kidney estimates based on creatinine can mislead when muscle mass is low. The team measured fat-free mass by an electrical body scan in hospital patients aged seventy-five and older.

Of more than three hundred patients screened, forty-three on the standard full dose had timed blood samples suitable for analysis. Lower fat-free mass tracked higher drug levels in a first pass, but the link faded once sex and kidney values were taken into account. The authors treat the signal as a question for larger studies, not a dosing rule.

Catalog record

CREATORTancrède de Jerphanion, Olivier Brière, Jennifer Gautier, Alexis Bourgeais, Myriam Mellou, Léa Bourreau, Cédric Annweiler, Mathieu Corvaisier
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13571488

Browse the full library · About the Tower of Babel